[HTML][HTML] CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma… - Nature medicine, 2021 - nature.com
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma… - Nature …, 2021 - europepmc.org
Cancer patients have high mortality from COVID-19, and the immune parameters that dictate
clinical outcomes remain unknown. In a cohort of 100 cancer patients hospitalized for …
clinical outcomes remain unknown. In a cohort of 100 cancer patients hospitalized for …
[HTML][HTML] CD8+ T cells contribute to survival in COVID-19 patients with hematologic cancers
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma… - Nature …, 2021 - ncbi.nlm.nih.gov
Cancer patients have high mortality from COVID-19, and the immune parameters that dictate
clinical outcomes remain unknown. In a cohort of 100 cancer patients hospitalized for …
clinical outcomes remain unknown. In a cohort of 100 cancer patients hospitalized for …
[引用][C] CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma… - Nature Medicine, 2021 - cir.nii.ac.jp
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma… - Nature …, 2021 - europepmc.org
Cancer patients have high mortality from COVID-19, and the immune parameters that dictate
clinical outcomes remain unknown. In a cohort of 100 cancer patients hospitalized for …
clinical outcomes remain unknown. In a cohort of 100 cancer patients hospitalized for …